Abstract
The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer's disease (AD). We aimed to examine the association between human blood levels of IL-33 and cognitive preservation in amnestic mild cognitive impairment (aMCI) and AD. A total of 100 participants (26 controls, 35 aMCI patients, and 39 AD patients) completed two Mini-Mental State Examinations (MMSEs) over a 1-year interval. In all 100 participants at the second MMSE, we examined the plasma levels of IL-33, IL-β, IL-1 receptor agonist (IL-1RA), beta amyloid (Aβ), and tau and apolipoprotein E (ApoE) genotyping; we also performed Hopkins Verbal Learning Test, Trail Making Test, forward and backward digit span, and Clinical Dementia Rating. IL-33 expression showed a positive trend among controls (1/26 = 3.8%), aMCI (9/35 = 25.7%), and AD (17/39 = 43.6%) (trend analysis: P < 0.001). Patients expressing IL-33 preserved their cognitive function compared with IL-33 non-expressing patients (1-year ΔMMSE, 0.16 ± 1.6 vs - 1.5 ± 2.6; P = 0.006). The cognitive preservation was not associated with the lower levels of Aβ, tau, and ApoE ε4, while higher levels of ApoE ε4 and phosphorylated ...Continue Reading
References
Aug 31, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Solomon S ShaftelM Kerry O'Banion
Feb 11, 2009·Molecular Psychiatry·J ChapuisJ C Lambert
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Marilyn S AlbertCreighton H Phelps
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Guy M McKhannCreighton H Phelps
Jul 8, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shafaqat AliMichael Uwe Martin
Jan 13, 2012·Alzheimer's Research & Therapy·Rachel F LaneHoward M Fillit
Mar 15, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Simantini GhoshM Kerry O'Banion
Jul 6, 2014·Alzheimer's Research & Therapy·Shuang WangBin Wang
Aug 26, 2014·Brain, Behavior, and Immunity·Yuriy PomeshchikTarja Malm
Oct 15, 2014·Proceedings of the National Academy of Sciences of the United States of America·Emma LefrançaisJean-Philippe Girard
Dec 2, 2014·Alzheimer's Research & Therapy·Katarina NäggaSebastian Palmqvist
Feb 11, 2015·Neuron·Sachin P GadaniJonathan Kipnis
Apr 17, 2015·Alzheimer's Research & Therapy·Peter ThériaultSerge Rivest
May 21, 2015·Nature Reviews. Neuroscience·Frank L HeppnerBurkhard Becher
Jun 27, 2015·Brain, Behavior, and Immunity·Paula KorhonenTarja Malm
Apr 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Amy K Y FuNancy Y Ip
Jun 7, 2016·Alzheimer's Research & Therapy·Malin Degerman GunnarssonLena Kilander
Oct 27, 2016·Nature Reviews. Immunology·Foo Yew LiewHeth Roderick Turnquist
Dec 15, 2016·Alzheimer's Research & Therapy·Jian-Hui WangYong-Xiang Zhang
Dec 20, 2016·Psychiatry Research·Pei-Shen HoChih-Sung Liang
Mar 6, 2017·Alzheimer's Research & Therapy·Róisín M McManus, Michael T Heneka
May 10, 2017·The Journal of Allergy and Clinical Immunology·Hideaki MoritaKenji Matsumoto
Aug 2, 2017·Translational Psychiatry·C CarlockY Lou
Dec 3, 2017·Scientific Reports·Francesca La RosaMario Clerici
Feb 9, 2018·Science·Ilia D VainchteinAnna V Molofsky
Nov 21, 2018·Alzheimer's Research & Therapy·Roger N RosenbergDoris Lambracht-Washington
Feb 2, 2019·Alzheimer's Research & Therapy·Omar A HalawaUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 25, 2019·Alzheimer's Research & Therapy·Carla M StartinAndré Strydom
Aug 10, 2019·Frontiers in Immunology·Caroline DreisHeinfried H Radeke
Oct 20, 2019·Alzheimer's Research & Therapy·Woo Shik ShinLin Jiang
Nov 9, 2019·Journal of Clinical Medicine·Chia-Lin TsaiFu-Chi Yang
Dec 5, 2019·Journal of Neuroinflammation·Josy AugustineMei Chen
Jan 2, 2020·Alzheimer's Research & Therapy·Samir Abu-RumeilehPiero Parchi